Moderna Inc. shares rose after the company posted a narrower third-quarter loss than Wall Street expected, a sign that its ...

Five top-selling drugs, in some cases, are costing Americans thousands in out of pocket expenses weekly and monthly. Here's ...

Merck's power purchase agreement (PPA) with SK Innovation E&S will supply 16 megawatts of renewable electricity to life ...

German diversified group Merck KGaA is preparing to put its pigments business up for sale to fund investments at its drugs ...

Germany's Merck KGgA said on Monday it has agreed to pay Swiss biotech Debiopharm up to 900 million euros ($1.08 billion) to ...

Although Merck (currently trading at $84.57 per share) has gained 7% over the last six months, it has trailed the S&P 500’s 21.3% return during that period. This may have investors wondering how to ...

Recent partnership announcements in the pharma industry reflects the community’s commitment to collaborative innovation, ...

The guidance change marks the latest adjustment Novo has made to its 2025 outlook as the company battles a changing market.

Donald Trump’s man in London reiterated the US president’s demands for the UK to pay pharmaceutical companies more money.